345 related articles for article (PubMed ID: 20133736)
1. Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules.
Hern JA; Baig AH; Mashanov GI; Birdsall B; Corrie JE; Lazareno S; Molloy JE; Birdsall NJ
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2693-8. PubMed ID: 20133736
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Regulation of Quaternary Organization of the M1 Muscarinic Receptor by Subtype-selective Antagonist Drugs.
Pediani JD; Ward RJ; Godin AG; Marsango S; Milligan G
J Biol Chem; 2016 Jun; 291(25):13132-46. PubMed ID: 27080256
[TBL] [Abstract][Full Text] [Related]
3. Development of a homogeneous high-throughput live-cell G-protein-coupled receptor binding assay.
Lee PH; Miller SC; van Staden C; Cromwell EF
J Biomol Screen; 2008 Sep; 13(8):748-54. PubMed ID: 18460694
[TBL] [Abstract][Full Text] [Related]
4. Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process.
Ilien B; Glasser N; Clamme JP; Didier P; Piemont E; Chinnappan R; Daval SB; Galzi JL; Mely Y
J Biol Chem; 2009 Jul; 284(29):19533-43. PubMed ID: 19451648
[TBL] [Abstract][Full Text] [Related]
5. A fluorescence anisotropy assay for the muscarinic M1 G-protein-coupled receptor.
Huwiler KG; De Rosier T; Hanson B; Vogel KW
Assay Drug Dev Technol; 2010 Jun; 8(3):356-66. PubMed ID: 20233092
[TBL] [Abstract][Full Text] [Related]
6. Ligand characterization using microphysiometry.
Pitchford S
Curr Protoc Neurosci; 2001 May; Chapter 7():Unit7.8. PubMed ID: 18428534
[TBL] [Abstract][Full Text] [Related]
7. Determination of the rate of muscarinic M1 receptor plasma membrane delivery using a regulated secretion/aggregation system.
Sawyer GW; Ehlert FJ; Hart JP
J Pharmacol Toxicol Methods; 2006; 53(3):219-33. PubMed ID: 16213169
[TBL] [Abstract][Full Text] [Related]
8. Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.
Gupta S; Singh RK; Nanda K; Chatterjee M; Tiwari A; Sundaram S; Gupta D; Chugh A; Dastidar S; Ray A
J Recept Signal Transduct Res; 2009; 29(2):100-6. PubMed ID: 19288301
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor.
Tahtaoui C; Parrot I; Klotz P; Guillier F; Galzi JL; Hibert M; Ilien B
J Med Chem; 2004 Aug; 47(17):4300-15. PubMed ID: 15294002
[TBL] [Abstract][Full Text] [Related]
10. Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors.
Huang XP; Nagy PI; Williams FE; Peseckis SM; Messer WS
Br J Pharmacol; 1999 Feb; 126(3):735-45. PubMed ID: 10188986
[TBL] [Abstract][Full Text] [Related]
11. Comparison of subcellular distribution and functions between exogenous and endogenous M1 muscarinic acetylcholine receptors.
Morishima S; Anisuzzaman ASM; Uwada J; Yoshiki H; Muramatsu I
Life Sci; 2013 Jul; 93(1):17-23. PubMed ID: 23727356
[TBL] [Abstract][Full Text] [Related]
12. The assessment of antagonist potency under conditions of transient response kinetics.
Christopoulos A; Parsons AM; Lew MJ; El-Fakahany EE
Eur J Pharmacol; 1999 Oct; 382(3):217-27. PubMed ID: 10556673
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent styryl dyes FM1-43 and FM2-10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy.
Mazzone SB; Mori N; Burman M; Palovich M; Belmonte KE; Canning BJ
J Physiol; 2006 Aug; 575(Pt 1):23-35. PubMed ID: 16728454
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
[TBL] [Abstract][Full Text] [Related]
15. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling.
Cai X; Bai B; Zhang R; Wang C; Chen J
Sci Rep; 2017 Jan; 7():40335. PubMed ID: 28091541
[TBL] [Abstract][Full Text] [Related]
16. Influence of MT7 toxin on the oligomerization state of the M1 muscarinic receptor.
Marquer C; Fruchart-Gaillard C; Mourier G; Grandjean O; Girard E; le Maire M; Brown S; Servent D
Biol Cell; 2010 Apr; 102(7):409-20. PubMed ID: 20170475
[TBL] [Abstract][Full Text] [Related]
17. Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization.
Calebiro D; Rieken F; Wagner J; Sungkaworn T; Zabel U; Borzi A; Cocucci E; Zürn A; Lohse MJ
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):743-8. PubMed ID: 23267088
[TBL] [Abstract][Full Text] [Related]
18. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.
Sheffler DJ; Williams R; Bridges TM; Xiang Z; Kane AS; Byun NE; Jadhav S; Mock MM; Zheng F; Lewis LM; Jones CK; Niswender CM; Weaver CD; Lindsley CW; Conn PJ
Mol Pharmacol; 2009 Aug; 76(2):356-68. PubMed ID: 19407080
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.
Daval SB; Kellenberger E; Bonnet D; Utard V; Galzi JL; Ilien B
Mol Pharmacol; 2013 Jul; 84(1):71-85. PubMed ID: 23604140
[TBL] [Abstract][Full Text] [Related]
20. A conserved motif in the membrane proximal C-terminal tail of human muscarinic m1 acetylcholine receptors affects plasma membrane expression.
Sawyer GW; Ehlert FJ; Shults CA
J Pharmacol Exp Ther; 2010 Jan; 332(1):76-86. PubMed ID: 19841475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
